Director, Consultation-Liaison Psychiatry
22 S. Greene Street, P1H04
Education and Training
Dr. Himelhoch received his medical degree at the University of Michigan School of Medicine (1994) and completed his residency training in general psychiatry at the University of California, San Francisco (1998). He completed a fellowship in health services research through the Robert Wood Johnson Clinical Scholars Program at Johns Hopkins School of Medicine (2003), where he concurrently received a Master Degree in Public Health from the Bloomberg School of Public Health (2003). Dr. Himelhoch additionally completed a fellowship in Implementation and Dissemination Science through the Implementation Research Institute (2012).
Dr. Himelhoch's research focuses on developing and studying the efficacy of innovative strategies aimed at improving the health and welfare of people with co-occurring psychiatric and substance use disorders. He has published over 60 peer reviewed publications and has received external funding as principal investigator from NIDA, NHBLI, NIMH, SAMHSA and the Veterans Affairs
Mental Health, HIV, Substance Use
1: Keith A, Dong Y, Shuter J, Himelhoch S*. Behavioral Interventions for Tobacco
Use in HIV-Infected Smokers: A Meta-Analysis. J Acquir Immune Defic Syndr. 2016
2: Blank MB, Himelhoch SS, Balaji AB, Metzger DS, Dixon LB, Rose CE, Oraka E,
Davis-Vogel A, Thompson WW, Heffelfinger JD. A multisite study of the prevalence
of HIV with rapid testing in mental health settings. Am J Public Health. 2014
3: Himelhoch S, Riddle J, Goldman HH. Barriers to implementing evidence-based
smoking cessation practices in nine community mental health sites. Psychiatr
Serv. 2014 Jan 1;65(1):75-80.
4: Teslyar P, Stock VM, Wilk CM, Camsari U, Ehrenreich MJ, Himelhoch S*.
Prophylaxis with antipsychotic medication reduces the risk of post-operative
delirium in elderly patients: a meta-analysis. Psychosomatics. 2013
5: Himelhoch S, Brown CH, Walkup J, Chander G, Korthius PT, Afful J, Gebo KA. HIV
patients with psychiatric disorders are less likely to discontinue HAART. AIDS.
2009 Aug 24;23(13):1735-42.